InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Alloway Paul. Officer active across 2 companies, notably Homology Medicines, Inc.. In total, 7 disclosures have been recorded. Split: 0 buy · 4 sells. Total volume traded: €29k. Activity tracked since 9 January 2023. The latest transaction was disclosed on 25 March 2024 (Cession). Regulator: SEC (Form 4). All data is free.
7 of 7 declarations